Carfilzomib: new treatment for multiple myeloma

Carfilzomib (Kyprolis) in combination with lenalidomide and dexamethasone is indicated for the treatment of multiple myeloma in adults who have received at least one prior therapy.

by Tulsi Pindolia
Carfilzomib is given by intravenous infusion together with oral lenalidomide and intravenous dexamethasone. | SCIENCE PHOTO LIBRARY
Carfilzomib is given by intravenous infusion together with oral lenalidomide and intravenous dexamethasone. | SCIENCE PHOTO LIBRARY

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package